A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas
Completed · Phase 1
Conditions studied: Gastrointestinal Neoplasms, Pancreatic Neoplasms
In brief
Radiotherapy plus Single-Agent Chemotherapy/Radiosensitization. Involved-field irradiation using 4-15 MV photons; plus Gemcitabine, NSC-613327.
Key facts
- Study ID
- NCT00001431
- Run by
- National Cancer Institute (NCI)
- People needed
- 20
- Starts
- 1995-02-01
- Expected to finish
- 2000-11-01
- Last updated by the study team
- 2008-03-04
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Cancer Institute (NCI) — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.